HER2-Positive Breast Cancer | Mark D Pegram, MD

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Positive Breast Cancer — Faculty Presentation 4: Considerations in the Care of Patients with Localized HER2-Positive Breast Cancer Receiving Neoadjuvant Systemic Therapy — Dr Pegram. CME information and select publications